Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 48Breast Neoplasms 8Neoplasms 4Leiomyoma 3Breast Neoplasms, Male 2Sexual Dysfunction, Physiological 1Prostate Adenocarcinoma 1Neoplasm Metastasis 1Myofibroma 1Breast Cancer Invasive 1Advanced Prostate Cancer 1Advanced Prostate Adenocarcinoma 1Adenocarcinoma 1

Interventions

Misoprostol 4relugolix 2ramosetron 1estradiol, norethindrone drug combination 1Tranexamic Acid 1Saline Solution 1Oxytocin 1Leuprolide 1Dinoprostone 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Myofibroma × Leuprolide × Clear all
NCT02736435 2018-02-06

Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound

Thunder Bay Regional Health Research Institute

Phase 3 Withdrawn

Leiomyoma, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡